Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02101593
Title Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Polaris Group
Age Groups: adult
Covered Countries USA

No variant requirements are available.